Neutrophil Lymphocyte Ratio (NLR) in COVID-19 Patients Receiving Convalescent Plasma Therapy
Article Sidebar
Main Article Content
Abstract
Recently, a new RNA virus from the Coronaviridae family was discovered, known as SARS-Cov-2. This virus causes pneumonia and inflammation in the body. One of the laboratory tests used to see inflammation in the body is the Neutrophil Lymphocyte Ratio, or often abbreviated as NLR. NLR is one of the markers of inflammation that can be used simply, efficiently, and reliably because of its high stability and sensitivity. Higher NLR values tend to lead to a severe and poor prognosis, so this test can be done by monitoring patients with confirmed Corona Virus Disease 2019 (COVID-19). The purpose of this study was to determine the neutrophil lymphocyte’s ratio in COVID-19 patients receiving convalescent plasma therapy. This research method is a quantitative observation using a descriptive approach. Quantitative observational research is used to analyze data in the form of numbers from the results of laboratory tests. The results obtained from 17 research subjects, namely the NLR values before convalescent plasma therapy were obtained in as many as 6 patients (35%) with normal NLR values below 3.13 and NLR values are increasing above 3.13 in as many as 11 patients (65%). Meanwhile, after convalescent plasma therapy, there were 8 patients (47%) with normal NLR below 3.13 and NLR values increasing above 3.13 as many as 9 patients (53%). This research concerns about changes in NLR values before and after convalescent plasma therapy, which before convalescent plasma therapy there were 6 patients with normal NLR values and after convalescent plasma therapy increased to 8 patients with normal NLR values which indicate a better good prognosis.
Downloads
Article Details
Copyright (c) 2022 Desyani Ariza, Andi Maya Kesrianti, Tazya Anggraini Ruslan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X. Articles clinical features of patients infected with 2019 novel coronavirus in Wuhan , China. 2020;497–506. https://doi.org/10.1016/S0140-6736(20)30183-5 DOI: https://doi.org/10.1016/S0140-6736(20)30183-5
Levani Y, Prasetya AD, Ramadhani SM. Coronavirus Disease 2019 (COVID-19): Pathogenesis, clinical manifestations and treatment options. J Med Heal [Internet]. 2021;17(1):44–57. https://doi.org/10.26714/magnamed.6.1.2019.31-37. DOI: https://doi.org/10.26714/magnamed.6.1.2019.31-37
Mardewi IGA, Yustiani NT. Gambaran hasil laboratorium pasien COVID-19 di RSUD Bali Mandara: sebuah studi pendahuluan [Overview of laboratory results of COVID-19 patients at Bali Mandara Hospital: a preliminary study]. Intisari Sains Medis. 2021;12:374–8. https://doi.org/10.15562/ism.v12i2.1000 DOI: https://doi.org/10.15562/ism.v12i2.1000
Harahap RJ. Clinical Characteristics of Coronavirus Disease 2019. J Prof Nurse Res. 2020;2(3):317–24.https://doi.org/10.37287/jppp.v2i3.145. DOI: https://doi.org/10.37287/jppp.v2i3.145
Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, Sinto R, Singh G, Nainggolan L, Nelwan EJ, Khie L, Widhani A, Wijaya E, Wicaksana B, Maksum M, Annisa F, Jasirwan OM, Yunihastuti E, Penanganan T, New I, … Cipto R. Coronavirus Disease 2019 : Tinjauan literatur terkini Coronavirus Disease 2019 [Review of Current Literatures] . 2020;7(1):45–67. https://doi.org/10.7454/jpdi.v7i1.415. DOI: https://doi.org/10.7454/jpdi.v7i1.415
Monica TH, Triyono T, Harly PR. Management of Convalescent Plasma Therapy for COVID-19 patients Third Edition Book. Surabaya: Media Partners Persada; 2021.
Supadmi, Francisca RS, Susilo, Tri DE, Mumpuni, Nurpuji. Literature review of Convalessed Plasma Therapy for COVID-19 patients. Medica Arter. 2021;3(1):53–61.doi : http://dx.doi.org/10.26714/medart.3.1.2021.53-60 DOI: https://doi.org/10.26714/medart.3.1.2021.53-60
Lagunas‐Rangel FA. Neutrophil ‐ to ‐ lymphocyte ratio and lymphocyte ‐ to ‐ C ‐ reactive protein ratio in patients with severe coronavirus disease 2019 (COVID‐19): A meta ‐ analysis. J Med Virol. 2020;1–2. https://doi.org/10.1002/jmv.25819. DOI: https://doi.org/10.1002/jmv.25819
Selanno Y, Widaningsih Y, Esa T, Arif M. Analysis of Neutrophil Lymphocyte Ratio and Absolute Lymphocyte Count as predictors of severity of COVID-19 Patients. 2021;27(2):184–189.p-ISSN 0854-4263; e-ISSN 2477-4685. Available at www.indonesianjournalofclinicalpathology.org. DOI: https://doi.org/10.24293/ijcpml.v27i2.1738
Maria M, Naim Nurlia, Arman Z. Description of the Amount of Lymphocyte and Neutrophil Ratio in acute appendicitis patients in Dr Wahidin Sudirohusodo Makassar Hospital. Jurnal Media Analis Kesehatan. J Media Anal Kesehat. 2019;10(2):119–25. https://doi.org/10.32382/mak.v10i2.1300.
Nusa KC, Mantik MFJ. Hubungan ratio neurtofil dan limfosit pada penderita penyakit infeksi virus dengue [Relationship between neutrophil and lymphocyte ratio in patients with Dengue Virus Infection]. 2015. https://doi.org/10.35790/ecl.3.1.2015.6764 DOI: https://doi.org/10.35790/ecl.3.1.2015.6764
Kastilong M, Tangkudung G, Khosama H. Rasio Neutrofil Limfosit dan luaran cedera kepala [Neutrophyl lymphocyte ratio and the outcome of traumatic brain injury]. 2018;1(2):20–28.Jurnal Sinaps. Available in www.jurnalsinaps.com
Fuad M, Oehadian A, Prihatni D, Marthoenis M. Neutrophil to Lymphocyte Ratio and COVID-19 Symptomps based severity at admission. Althea Med J. 2021;8(1):1–6. https://doi.org/10.15850/amj.v8n1.2255 DOI: https://doi.org/10.15850/amj.v8n1.2255
Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J, Kong Y, Liu Y, Xu H, Deng MES, Zhang X, Li C, Wang C, Shisheng Su LZ, Liu JYZ. Effect of Convalescent Plasma Therapy on time to clinical improvement in patients with severe and life-threatening COVID-19 a randomized clinical trial. JAMA. 2020;324(5):460--470 doi:10.1001/jama.2020.10044 DOI: https://doi.org/10.1001/jama.2020.10044
Damo NY, Porotu’o, John P, Rambert GI, Rares FES. Diagnostik Coronavirus Disease 2019 (COVID-19) dengan pemeriksaan laboratorium mikrobiologi klinik [Diagnostics of Coronavirus Disease 2019 (COVID-19) with clinical microbiology laboratory examination]. eBiomedik. 2021;9(1):77–86. doi : https://doi.org/10.35790/ebm.9.1.2021.31899 DOI: https://doi.org/10.35790/ebm.v9i1.31899
Ye M, Fu D, Ren Y, Wang F, Wang D, Zhang F, et al. Treatment with convalescent plasma for COVID-19 patients in Wuhan, China. J Med Virol [Internet]. 2020;92:1890–901.doi: 10.1002/jmv.25882 DOI: https://doi.org/10.1002/jmv.25882
Perhimpunan Dokter Spesialis Patologi Klinik dan Kedokteran Laboratorium Indonesia (PDS PatKLIn). 2020. Usulan panduan pemeriksaan laboratorium COVID-19 [Proposed COVID-19 laboratory examination guidelines]. www.pdspatklin.or.id
Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HH X, Luo M. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in. J Infect. 2020;81:6–12. https://doi.org/10.1016/j.jinf.2020.04.002. DOI: https://doi.org/10.1016/j.jinf.2020.04.002
Maulana MS. Effectiveness of the Efficacy of Convalescent Plasma Therapy in COVID-19 Patients. J Med Heal. 2020;7(3):7–14. https://doi.org/10.32539/JKK.V7I3.12297. DOI: https://doi.org/10.32539/JKK.V7I3.12297
Maria, Nurlia Naim & ZA. Description of The amount of lymphocyte and neutrophil ratio in acute appendicitis patients in Dr Wahidin Sudirohusodo Makassar Hospital. J Heal Anal Media. 2019;10(2):119–25. https://doi.org/10.32539/JKK.V7I3.12297. DOI: https://doi.org/10.32382/mak.v10i2.1300
Nugroho A, Suwarman AMN. Relationship between Neutrophil-Lymphocyte Ratio and sequencial organ failure assessment score in patients treated in the Intensive Care Unit. J Perioper Anesth. 2013;1(3):189–96. https://doi.org/10.15851/jap.v1n3.198. DOI: https://doi.org/10.15851/jap.v1n3.198
Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek List. 2001;102(1):5–14. Department of Anaesthesiology and Intensive Care medicine, St. Elisabeth Cancer Institute, Bratislava. PMID : 11723675. Available in pubmed.ncbi.nlm.nih.gov
Xing-hai Chen, Yong-jie Yin JZ. Sepsis and immune response. World J Emerg Med. 2011;2(2):88–92.PMCID:PMC4129694; PMID: 25214990. Available in pubmed.ncbi.nlm.nih.gov DOI: https://doi.org/10.5847/wjem.j.issn.1920-8642.2011.02.009
Fabiano PS VN. Cell death during sepsis : integration of disintegration in the inflammatory response to overwhelming infection. Apoptosis. 2009;14:509–21https://doi.org/10.1007/s10495-009-0320-3. DOI: https://doi.org/10.1007/s10495-009-0320-3
Jacqueline PBC. An overview of the immune system. Lancet. 2001;357:1777–90. https://doi.org/10.1016/S0140-6736(00)04904-7. DOI: https://doi.org/10.1016/S0140-6736(00)04904-7
Ariza, Desyani, Ferdhyanti AU. Routine Hematological Overview of COVID-19 infected patients before and after Convalescent Plasma Therapy. J Med Lab Sci Technol [Internet]. 2021;4(2):93–8. Available from: https://doi.org/10.21070/medicra.v4i2.1615.
